Dr. Yuan Yuan, MD PhD

Claim this profile

City of Hope Medical Center

Expert in Breast Cancer
Studies Colorectal Cancer
14 reported clinical trials
46 drugs studied

Area of expertise

1Breast Cancer
Global Leader
Yuan Yuan, MD PhD has run 12 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER negative
2Colorectal Cancer
Yuan Yuan, MD PhD has run 2 trials for Colorectal Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
Stage III

Affiliated Hospitals

Image of trial facility.
City Of Hope Medical Center
Image of trial facility.
Cedars-Sinai Medical Center

Clinical Trials Yuan Yuan, MD PhD is currently running

Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Immunotherapy + Hormone Therapy

for Advanced Breast Cancer

This phase II trial studies how well pembrolizumab works when given together with endocrine therapy and palbociclib in treating postmenopausal patients with newly diagnosed stage IV estrogen receptor positive breast cancer that has spread to other parts of the body (metastatic). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Estrogen can cause the growth of breast cancer cells. Fulvestrant blocks the use of estrogen by the tumor cells. Letrozole lowers the amount of estrogen made by the body. This may help stop the growth of tumor cells that need estrogen to grow. Palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab, palbociclib, and letrozole or fulvestrant may be an effective treatment for patients with stage IV estrogen receptor positive breast cancer.
Recruiting3 awards Phase 216 criteria

More about Yuan Yuan, MD PhD

Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Yuan Yuan, MD PhD has experience with
  • Pembrolizumab
  • Palbociclib
  • Ribociclib
  • Biospecimen Collection
  • Balstilimab
  • Ivermectin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yuan Yuan, MD PhD specialize in?
Yuan Yuan, MD PhD focuses on Breast Cancer and Colorectal Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Yuan Yuan, MD PhD currently recruiting for clinical trials?
Yes, Yuan Yuan, MD PhD is currently recruiting for 10 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Yuan Yuan, MD PhD has studied deeply?
Yes, Yuan Yuan, MD PhD has studied treatments such as Pembrolizumab, Palbociclib, Ribociclib.
What is the best way to schedule an appointment with Yuan Yuan, MD PhD?
Apply for one of the trials that Yuan Yuan, MD PhD is conducting.
What is the office address of Yuan Yuan, MD PhD?
The office of Yuan Yuan, MD PhD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.